Thus, the adverse events mentioned earlier should not discourage healthcare providers from considering treatment with GLP-1RAs
As of August 6, only one dosage of Wegovy, from Novo Nordisk, Inc
The FDA has announced a public advisory committee meeting later this summer to consider moving specific peptides to the 503A bulks list[1], which could reopen the door for licensed compounding pharmacies to prepare them
The monitoring is probably more intensive in the early part of the prescription of the drug, says Dr Korman
Environ Health Perspect 127(8):087005 Gimenez-Asensio MJ, Hernandez AF, Romero-Molina D, Gonzalez-Alzaga B, Luzardo OP, Henrquez-Hernndez LA, Boada LD, Garca-Corts H, Lopez-Flores I, Sanchez-Piedra MD, Aguilar-Garduo C (2023) Effect of prenatal exposure to organophosphates and pyrethroid pesticides on neonatal anthropometric measures and gestational age